chr16-69647057-A-G
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 1P and 4B. PVS1_SupportingBS2
The NM_138714.4(NFAT5):c.1A>G(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000157 in 1,596,720 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_138714.4 start_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152142Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 exome AF: 0.0000145 AC: 21AN: 1444578Hom.: 0 Cov.: 31 AF XY: 0.0000154 AC XY: 11AN XY: 715880 show subpopulations
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152142Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74316 show subpopulations
ClinVar
Submissions by phenotype
Immunodeficiency Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. The current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in NFAT5 cause disease. This sequence change affects the initiator methionine of the NFAT5 mRNA. The next in-frame methionine is located at codon 27. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with NFAT5-related conditions. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at